View in EDS

Dual EZH1/2 inhibition enhances DNMT inhibitor efficacy in colon cancer through targeting H3K27me1.

Saved in:
Bibliographic Details
Title: Dual EZH1/2 inhibition enhances DNMT inhibitor efficacy in colon cancer through targeting H3K27me1.
Authors: Chomiak AA; Department of Epigenetics, Van Andel Institute, Grand Rapids, Michigan 49503, USA., Wiseman AK; Department of Epigenetics, Van Andel Institute, Grand Rapids, Michigan 49503, USA., Hrit J; Department of Epigenetics, Van Andel Institute, Grand Rapids, Michigan 49503, USA., Liu Y; Department of Epigenetics, Van Andel Institute, Grand Rapids, Michigan 49503, USA.; Van Andel Institute Graduate School, Grand Rapids, Michigan 49503, USA., Stransky S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA., Sidoli S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA., Tiedemann RL; Department of Epigenetics, Van Andel Institute, Grand Rapids, Michigan 49503, USA., Rothbart SB; Department of Epigenetics, Van Andel Institute, Grand Rapids, Michigan 49503, USA.; Van Andel Institute Graduate School, Grand Rapids, Michigan 49503, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Sep 18. Date of Electronic Publication: 2025 Sep 18.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.09.16.676613